I am a postdoctoral researcher at the Ludwig Institute for Cancer Research, University of Oxford, specialising in endothelial cell function and cardiac and microvascular remodeling in disease. My research focuses on developing functional 3D vascularised organoids and microtissues using microfluidics to enhance our understanding of disease mechanisms and drive therapeutic innovations.In addition to my academic work, I am the Co-Founder of TrialeX, a platform dedicated to revolutionising diversity, recruitment, and retention in clinical trials, with the mission of making life-saving medical treatments more accessible globally.